- 25N-NBOH3Me
- N-(2-Hydroxy-3-methylbenzyl)-4-nitro-2,5-dimethoxyphenethylamine
Wallach, J; McCorvy, J; Halberstadt, A. Selective, partial, and arrestin-biased 5-HT2A agonists with utility in various disorders Patent WO 2022/241006 A1, 17 Nov 2022. 11.7 MB. #18
Wallach, J; Cao, AB; Calkins, MM; Heim, AJ; Lanham, JK; Bonniwell, EM; Hennessey, JJ; Bock, HA; Anderson, EI; Sherwood, AM; Morris, H; de Klein, R; Klein, AK; Cuccurazzu, B; Gamrat, J; Fannana, T; Zauhar, R; Halberstadt, AL; McCorvy, JD. Identification of 5-HT2A receptor signaling pathways responsible for psychedelic potential bioRxiv, 31 Jul 2023, 2023.07.29.551106. 9.8 MB. https://doi.org/10.1101/2023.07.29.551106 #25N-NB-2-OH-3-Me (18) LC,MS,NMR
Wallach, J; Cao, AB; Calkins, MM; Heim, AJ; Lanham, JK; Bonniwell, EM; Hennessey, JJ; Bock, HA; Anderson, EI; Sherwood, AM; Morris, H; de Klein, R; Klein, AK; Cuccurazzu, B; Gamrat, J; Fannana, T; Zauhar, R; Halberstadt, AL; McCorvy, JD. Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential Nat. Commun., 15 Dec 2023, 14 (1), 8221. 14.9 MB. https://doi.org/10.1038/s41467-023-44016-1 #18 MS,NMR
Duan, W; Cao, D; Wang, S; Cheng, J. Serotonin 2A receptor (5-HT2AR) agonists: Psychedelics and non-hallucinogenic analogues as emerging antidepressants Chem. Rev., 10 Jan 2024, 124 (1), 124–163. 12.6 MB. https://doi.org/10.1021/acs.chemrev.3c00375 #155